Pharmafile Logo
Pharmafocus logo
Advanced Search

NICE

Showing 15 posts of 866 posts found.

Rawlins image

Sir Michael Rawlins appointed chair of MHRA

November 4, 2014
Manufacturing and Production, Medical Communications, Sales and Marketing MHRA, NHS, NICE, gordon duff, michael rawlins

The Medicines and Healthcare Products Regulatory Agency (MHRA) has confirmed that former NICE head Sir Michael Rawlins is to serve …

News
GSK image

NICE backs GSK’s leukaemia drug Arzerra following price cut

November 4, 2014
Sales and Marketing Arzerra, CLL, GSK, NHS, NICE, leukaemia

NICE has recommended that GlaxoSmithKline’s Arzerra be prescribed under the NHS for patients with chronic lymphocytic leukaemia (CLL), after a …

News

UK doctors are ignoring statin guidance

November 3, 2014
Sales and Marketing British Medical Association, GPs, NHS, NICE, Royal College of GPs, Royal College of Physicians, statins

A survey of UK doctors has found that many are refusing to apply NICE advice to offer statin therapy to …

News
Pradaxa image

NICE recommends new indication for troubled Pradaxa

October 31, 2014
Sales and Marketing Boehringer, NHS, NICE, Pradaxa, dabigatran, ingelheim, warfarin

NICE has recommended Boehringer Ingelheim’s controversial anti-blood clotting drug Pradaxa for treating and preventing potentially-fatal blood clots in the legs …

News
nhs_parliament_2_8

Cancer Drugs Fund ‘papering over the cracks of a bigger issue’

October 29, 2014
Medical Communications, Research and Development, Sales and Marketing Cancer, Kadcyla, NICE, breast cancer, reform

Breakthrough Breast Cancer has raised concerns to the government this week over the ever-increasing price of new oncology medicines. Over …

News
Mark Baker image

NICE under increased pressure over conflicts of interest

October 22, 2014
Sales and Marketing GPs, NHS, NICE, UK, baker, conflict, mccoll, wollaston

A group of influential doctors is calling on the government to tighten up NICE’s conflicts of interests policy. In a …

News
Glivec image

Novartis cancer drug beating path to NHS

October 17, 2014
Sales and Marketing GIST, Glivec, NHS, NICE, imatinib, uturn

NICE has issued final draft guidance recommending Novartis’s Glivec for up to three years in people who have had a …

News

NICE not recommending Dendreon cancer vaccine

October 16, 2014
Sales and Marketing Dendreon, NHS, NICE, Provenge, sipuleucel-T, therapeutic cancer vaccine

NICE has issued preliminary draft guidance not recommending Dendreon’s therapeutic cancer vaccine Provenge for prostate cancer in people whose disease …

News

NICE releases ‘person-centred’ medicines optimisation guidelines

October 14, 2014
Research and Development, Sales and Marketing ABPI, NHS, NICE, UK, WHO, Whitehead

NICE has recently released the draft of its first guidance on medicines optimisation that it hopes will be more person-centered …

News
ABPI image

Public opinion divided over UK drugs spend

October 7, 2014
Medical Communications, Research and Development, Sales and Marketing ABPI, CDF, NHS, NICE, PPRS, UK, coalition, drugs spending, government

A new survey conducted for the ABPI shows that public opinion on whether the UK spends enough money on medicines …

News
Roche image

Roche falls foul of NICE rules, again

October 3, 2014
Medical Communications, Sales and Marketing CLL, Gazyvaro, NICE, Roche, blood cancer, oncology

Uncertainties in the data and high cost have seen NICE make an initial rejection of Roche’s new blood cancer drug …

News
Charity image

Charities must be clear about pharma funding

October 1, 2014
Medical Communications, Sales and Marketing ABPI, NICE, Sativex, charity, funding, mind, pharma

There is growing need for transparency around patient groups and health charities as they are widely perceived to be independent …

News

GSK melanoma drug sees quick NICE nod

September 18, 2014
Sales and Marketing Cancer, GSK, NICE, Tafinlar, Yervoy, dabrafenib, melanoma, skin cancer

NICE is recommending GlaxoSmithKline’s new melanoma treatment Tafinlar (dabrafenib) after the firm offered a discount for its medicine. In final …

News

NICE reform put on hold – for now

September 17, 2014
Sales and Marketing Dillon, NHS, NHS England, NICE, market access, vba

The reforming of NICE has been put on hold as the watchdog believes more changes must be wrought to deal …

News

Cancer drug gains first early UK access grant

September 17, 2014
Research and Development, Sales and Marketing Cancer, NICE, UK, keytruda, oncology, pin, promising

A new type of cell therapy for cancer has become the first to be deemed by the UK government as …

News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026